Vectus Biosystems

Vectus Biosystems Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Vectus Biosystems (VBS.AX) as of Oct 18, 2026 is 5.18. In the previous year, Net Debt to Free Cash Flow Ratio was 0.06 — a change of 8,332.49% (higher).

Net Debt/FCF

5.18

YoY

8,332.49%

Last updated:

Net Debt to Free Cash Flow Ratio of Vectus Biosystems is 2026 5.18 . Net Debt to Free Cash Flow Ratio of Vectus Biosystems was 2025 0.06 . It decreases by 8,332.49% higher compared to the previous year.

The Vectus Biosystems Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2019
-1.81 AUD
Jan 1, 2020
-1.84 AUD
Jan 1, 2021
-0.89 AUD
Jan 1, 2022
-1.26 AUD
Jan 1, 2023
1.22 AUD
Jan 1, 2024
0.37 AUD
Jan 1, 2025
0.06 AUD
Jan 1, 2026
5.18 AUD
The Vectus Biosystems Net Debt/FCF history
YEARNet Debt/FCFYoY
5.18+8,332.49%
0.06-83.46%
0.37-69.45%
1.22-196.48%
-1.26+41.26%
-0.89-51.56%
-1.84+1.67%
-1.81+188.69%
-0.63-1,039.68%
0.07-95.96%
1.65-76.45%
7.02+2,094.36%
0.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vectus Biosystems Stock analysis

What does Vectus Biosystems do? Vectus Biosystems Ltd, based in Rosebery, Australia, operates in the Health Care sector within Biotechnology. The company focuses on drug discovery and development, particularly for fibrosis and hypertension treatments, including conditions affecting the heart, kidneys, and liver. Its lead compound, VB0004, targets tissue hardening and high blood pressure. Vectus also develops Accugen, a platform for accurate DNA and RNA quantification in laboratory testing through its subsidiary Accugen Pty Limited. Vectus Biosystems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectus Biosystems stock

Net Debt to Free Cash Flow Ratio of Vectus Biosystems is 5.18 in 2026.

Net Debt to Free Cash Flow Ratio of Vectus Biosystems changed from 0.06 to 5.18, representing a 8,332.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Vectus Biosystems since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Vectus Biosystems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Vectus Biosystems

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vectus Biosystems